UCB USA

UCB USA Official U.S. page for UCB Biopharma. Patients are at the heart of everything we do. Learn more at www.ucb-usa.com.

UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology. We are unwavering in our purpose: delivering moments that matter for people impacted by severe diseases, now and into the future. People are at the heart of everything we do, inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to be the patient-preferred biopharma leader by delivering medicines and solutions that improve lives while creating value for society.

12/03/2025

📍 Join us at Dec. 5 - 9 in Atlanta to learn how we’re building on our more than 30-year legacy of partnership and innovation in epilepsy 💜​

From debuting Under the Lights, a feature film about living with epilepsy, to sharing 21 new abstracts and clinical data with the community, we’re looking forward to an event full of collaboration and invaluable insight.​

Visit booth 205 to connect on the urgent realities of epilepsy and DEE care, our goals to advance medicines beyond seizure control to disease modification, and so much more. ​

When this community comes together, we make an impact on the families living with epilepsy and rare syndromes.​

Learn more at https://bit.ly/441E5PM.

We’re partnering with Citizen Health to advance data and technology in ways that improve care for people living with epi...
12/02/2025

We’re partnering with Citizen Health to advance data and technology in ways that improve care for people living with epilepsy and rare diseases. By working together, we can make research faster, more patient-centered, and ultimately help close gaps in understanding and treatment, bringing us closer to better outcomes for the communities we serve. Learn more about the partnership here: https://bit.ly/4phJ2wC

12/01/2025

Recognizing rheumatic conditions early can reshape a patient’s future - and catching symptoms sooner helps people stay active, independent, and connected to the parts of life that matter most.​

We’re working with clinicians across the rheum and derm communities to strengthen the pathways that lead to earlier diagnosis, from expanding awareness of early warning signs to supporting smarter, more coordinated care systems. When we close gaps in recognition, we open doors to improved long-term outcomes.​

Learn more at https://bit.ly/4pidAym.

11/30/2025

At the HS Connect - Hidradenitis Suppurativa Connect event in Times Square, HS warriors shared more than words, they shared truths about the impact of community.​

Perseverance, community, and self-acceptance all come from a support system that has helped us partner to build awareness and improve care for this often-overlooked and misunderstood condition.​

Learn more at https://bit.ly/4jzzGIO.

11/26/2025

For over 30 years, we’ve been serving the epilepsy community, working hand in hand with advocacy groups like Dravet Syndrome Foundation, caregivers, and patients to drive meaningful change. 💜​

Bringing these voices to the table is fundamental to our work to address the urgent realities of living with epilepsy and rare syndromes.​

Watch the full conversation with Mary Anne Meskis, CEO of the Dravet Syndrome Foundation here: https://bit.ly/48hUYsg

On our latest Raring to Listen podcast episode to hear how collaboration continues to inspire innovation and impact via https://www.viprarecare.com/.

11/24/2025

Awareness opens the door to understanding. 💜​

Throughout our 30+ year legacy working with the community, we’ve partnered with families living with epilepsy and advocates like the Dravet Syndrome Foundation and LGS Foundation to reduce stigma and build compassion through education.​

But, we know there’s still so much work to be done, especially as we learn more about rare, life threatening epilepsies like Lennox-Gastaut syndrome and Dravet syndrome.​

Join us in showing your support. Comment below and share how we can work together to improve real-world outcomes for the 1-in-26 Americans who may develop epilepsy throughout their lives.

Learn more at https://bit.ly/4mxzoUf.

11/21/2025

Every rheumatology patient journey is different, and that’s why the way we show up should be different too. 💙​

Instead of a one-size-fits-all approach, we must support tailored solutions grounded in the unique needs of each patient and strengthened by collaboration among HCPs, providers, advocates, and patients and their families. By bringing every stakeholder to the table, we can help build comprehensive care strategies that extend far beyond medicine.​

Learn more at https://bit.ly/4p5yDUo.

11/20/2025

Improving access means meeting patients where they are. 💙​

Jane Thompson, UCB’s Head of U.S. Market Access, shares three key ways we’re driving meaningful impact:​

1️⃣ Increasing awareness and ensuring there are solutions for our patients ​
2️⃣ Enhancing affordability through insurance partnerships and patient assistance programs​
3️⃣ Providing personalized support through UCB Cares​

Together, these initiatives reflect our ongoing commitment to ensuring that every patient can access the care they need when they need it.

Learn more at https://bit.ly/4a0grac.

11/19/2025

Finding answers for ultra-rare conditions can take years, and for families affected by thymidine kinase 2 deficiency (TK2d), the journey to a diagnosis is often long and uncertain.​

Today, new possibilities are emerging for those living with TK2d. As we look ahead, we remain dedicated to advancing science, raising awareness, and driving innovation to help elevate the lives of people impacted by this ultra-rare, life-threatening, genetic
mitochondrial disease.​

Learn more about how we’re expanding our rare disease portfolio and supporting the TK2d community at https://bit.ly/4opPd1b. 💚​



©2025 UCB, Inc., Smyrna, GA 30080. All rights reserved. US-MT-2500173

11/18/2025

Small steps, big hearts. 💜🙏​

At Camp Small Steps, kids, siblings, and caregivers had a lot to say and their words were filled with laughter, love, and joy.​

Hosted by Eleni Haralabidis from UCB, this video captures the voices that make Camp Small Steps so special, reminding us that camp isn’t just about activities, but about belonging, connection, and community.​

Developed in partnership with the Dravet Syndrome Foundation, Camp Small Steps is where every family finds support, understanding, and a reason to smile.​

Learn more at ShineForwardWithDravet.com

11/17/2025

Every moment matters for those living with rare epilepsies like Lennox-Gastaut syndrome.​

That’s why we bring a sense of urgency to our work in developing innovative solutions for rare and severe epilepsies each day. As Brad Chapman shares, our mission has always been to meet patients where they are, shaping a future defined by progress, partnership, and care that never stands still.

11/13/2025

Partnership in action. 💙​

From new data to deeper dialogue, came together with the neuromuscular community at to advance care for people living with MG.​

We’re proud to help lead the conversation — listening, learning, and collaborating to create impact that lasts far beyond the conference floor. Learn more on the UCB blog: https://bit.ly/3K1GVgX

Address

Atlanta, GA
30080

Alerts

Be the first to know and let us send you an email when UCB USA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to UCB USA:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram